Foster-Cheek Kaye I

CIK 00013126224 companiesNEW BRUNSWICK, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001312622

Recent Transactions

50 trades

Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01+39,062→ 39,062 total
Disposition to Issuer
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01−39,062→ 0 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01+13,510→ 13,510 total
Disposition to Issuer
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01−9,006→ 0 total
Disposition to Issuer
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01−45,000→ 0 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01+9,006→ 9,006 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01+45,000→ 45,000 total
Disposition to Issuer
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-08-01−13,510→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-06-20−2,120→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-20+2,120→ 7,468 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-06-18+2,816→ 2,816 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-06-18+15,768→ 15,768 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2025-06-04+55,000→ 55,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2024-06-20+11,774→ 11,774 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-06-20+2,120→ 2,120 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-06-13+3,388→ 8,912 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2024-06-13−3,388→ 0 total
Gift
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-06-13−3,564→ 5,348 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2024-06-12+45,000→ 45,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-03-07$31.62/sh−1,285→ 5,524 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-03-06$31.99/sh−4,415→ 6,809 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2024-03-05$32.21/sh−300→ 11,224 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2023-08-09−25,000→ 4,307 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-08-09$25.96/sh−25,000→ 11,524 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-08-09$18.09/sh+25,000→ 36,524 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock unit
2023-06-21−4,975→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-06-21+4,975→ 11,524 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2023-06-14+39,062→ 39,062 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2023-06-13+3,388→ 3,388 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2023-06-13+18,958→ 18,958 total
Gift
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2023-01-13−2,200→ 6,549 total
Award
Prime Medicine, Inc.$PRME
Stock Option (right to buy)
2022-10-19+9,006→ 9,006 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2022-06-21+29,307→ 29,307 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock unit
2022-06-21+4,975→ 4,975 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2022-05-20+1,585→ 8,749 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock unit
2022-05-20−1,585→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2021-05-28+1,686→ 7,164 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2021-05-28−1,686→ 0 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock unit
2021-05-20+1,585→ 1,585 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2021-05-20+8,888→ 8,888 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2020-05-29−1,878→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-05-29+1,878→ 5,478 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2020-05-28+1,686→ 1,686 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2020-05-28+8,096→ 8,096 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2019-05-31−1,400→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2019-05-31+1,400→ 3,600 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2019-05-29+8,919→ 8,919 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2019-05-29+1,878→ 1,878 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2018-06-14−9,000→ 0 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2018-06-14$94.30/sh−839→ 2,200 total

Companies

Recent Filings

Address

JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA

NEW BRUNSWICK, NJ, 08933

View on SEC.gov